The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Stepanova E.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Krutikova E.V.

Federal State Budgetary Scientific Institution «Institute of Experimental Medicine», 197376 St. Petersburg, Russia, Akad. Pavlova Street, 12, Russia

Kiseleva I.V.

Federal State Budgetary Scientific Institution «Institute of Experimental Medicine», 197376 St. Petersburg, Russia, Akad. Pavlova Street, 12, Russia;
Saint-Petersburg State University, 199034, St. Petersburg, Universitetskaya Nab., 7-9, Russia

Rudenko L.G.

Federal State Budgetary Scientific Institution «Institute of Experimental Medicine», 197376 St. Petersburg, Russia, Akad. Pavlova Street, 12, Russia

The spatial location of single amino acid substitutions in proteins of cold-adapted influenza B viruses and their impact upon cold adaptation

Authors:

Stepanova E.A., Krutikova E.V., Kiseleva I.V., Rudenko L.G.

More about the authors

Read: 2409 times


To cite this article:

Stepanova EA, Krutikova EV, Kiseleva IV, Rudenko LG. The spatial location of single amino acid substitutions in proteins of cold-adapted influenza B viruses and their impact upon cold adaptation. Molecular Genetics, Microbiology and Virology. 2018;36(3):13‑24. (In Russ.)
https://doi.org/10.17116/molgen20183603113

Recommended articles:
DNA base editors are a promising tool to gene therapy of human viral infe­ctions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):4-8
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Infe­rior alveolar nerve injury and sensory reha­bilitation of the lower lip. Plastic Surgery and Aesthetic Medi­cine. 2025;(3):91-99
The exoskeleton of the hand in modern habi­litation and reha­bilitation (analytical review). Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(3):53-61

References:

  1. Massin P, van der Werf S, Naffakh N. Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses. Journal of Virology. 2001;75(11):5398-5404.
  2. Isakova-Sivak I, Rudenko L. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. Expert Review of Vaccines. 2015;14(10):1313-1329.
  3. Belshe RB, Coelingh K, Ambrose CS, et al. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. 2010;28(9):2149-2156.
  4. Chen Z, Aspelund A, Kemble G. Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology. 2006;345(2):416-423.
  5. Kiseleva IV, Voeten JTM, Teley LCP, et al. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus. The Journal of General Virology. 2010;91(Pt 4):931-937.
  6. Hoffmann E, Mahmood K, Chen Z, et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. Journal of Virology. 2005;79(17):11014-11021.
  7. Alexandrova GI. Attenuated cold-adapted influenza virus strain V/Leningrad/14/17/55 for preparing live attenuated influenza vaccine strains. Patent RF №2068271; 1996. (In Russ.)
  8. Ghendon YuZ, Markushin SG, Tsfasman TM, et al. New cold-adapted donor strains for live influenza vaccine. Vopr Virusol. 2013;58(1):11-17. (In Russ.)
  9. Katinger H, Egorov A, Ferko B, et al. Live influenza vaccine and method of manufacture. Patent WO 2002024876 A2. Google Patents, WO Patent App. PCT/EP2001/011,087. 2002. Available at: https://www.google.com/patents/WO2002024876A2 (assessed 5 July 2017).
  10. Seo S-U, Byun Y-H, Lee E-Y, et al. Development and characterization of a live attenuated influenza B virus vaccine candidate. Vaccine. 2008;26(7):874-881.
  11. Lee E-Y, Lee K-H, Jung E-J, et al. Genotyping and screening of reassortant live-attenuated influenza B vaccine strain. Journal of Virological Methods. 2010;165(2):133-138.
  12. Jang YH, Lee E-Y, Byun YH, et al. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine. 2014;32(5):535-543.
  13. Maassab HF, DeBorde DC. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine. 1985;3(5):355-369.
  14. Donabedian AM, DeBorde DC, Maassab HF. Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence. Microbial Pathogenesis. 1987;3(2):97-108.
  15. Rudenko L, Alexandrova G. Current strategies for the prevention of influenza by the Russian cold-adapted live influenza vaccine among different populations. International Congress Series. 2001;1219:945-950.
  16. Alexandrova GI, Maassab HF, Kendal AP, et al. Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. Vaccine. 1990;8(1):61-64.
  17. Resa-Infante P, Jorba N, Coloma R, Ortín J. The influenza RNA synthesis machine. RNA Biology. 2011;8(2):207-215.
  18. Liu Y, Yang Y, Fan J, et al. The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism. The Journal of Biological Chemistry. 2015;290(14):9141-9149.
  19. Reich S, Guilligay D, Pflug A, et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature. 2014;516(7531):361-366.
  20. Pflug A, Guilligay D, Reich S, Cusack S. Structure of influenza A polymerase bound to the viral RNA promoter. Nature. 2014;516(7531):355-360.
  21. Massin P, van der Werf S, Naffakh N. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. Journal of Virology. 2001;75(11):5398-5404.
  22. Subbarao EK, London W, Murphy BR. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. Journal of Virology. 1993;67(4):1761-1764.
  23. Boivin S, Cusack S, Ruigrok RWH, Hart DJ. Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. The Journal of Biological Chemistry. 2010;285(37):28411-28417.
  24. He X, Zhou J, Bartlam M, et al. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature. 2008; 454 (7208):1123-1126.
  25. Obayashi E, Yoshida H, Kawai F, et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature. 2008; 454 (7208):1127-1131.
  26. Ng AK-L, Lam MK-H, Zhang H, et al. Structural basis for RNA binding and homo-oligomer formation by influenza B virus nucleoprotein. Journal of Virology. 2012;86(12):6758-6767.
  27. Liu M, Lam MK-H, Zhang Q, et al. The functional study of the N-terminal region of influenza B virus nucleoprotein. PLoS ONE. 2015;10(9): e0137802.
  28. Wanitchang A, Narkpuk J, Jongkaewwattana A. Nuclear import of influenza B virus nucleoprotein: involvement of an N-terminal nuclear localization signal and a cleavage-protection motif. Virology. 2013;443(1):59-68.
  29. Hatta M, Kohlmeier CK, Hatta Y, et al. Region required for protein expression from the stop-start pentanucleotide in the M gene of influenza B virus. Journal of Virology. 2009;83(11):5939-5942.
  30. Safo MK, Musayev FN, Mosier PD, et al. Crystal structures of influenza A virus matrix protein M1: variations on a theme. PLoS ONE. 2014;9(10): e109510.
  31. Cao S, Jiang J, Li J, et al. Characterization of the nucleocytoplasmic shuttle of the matrix protein of Influenza B virus. Journal of Virology. 2014;88(13):7464-7473.
  32. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research. 2014;42(1):252-258.
  33. Wang J, Pielak RM, McClintock MA, Chou JJ. Solution structure and functional analysis of the influenza B proton channel. Nature Structural & Molecular Biology. 2009;16(12):1267-1271.
  34. Wakefield L, Brownlee GG. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Research. 1989;17(21):8569-8580.
  35. Sha B, Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nature Structural Biology. 1997;4(3):239-244.
  36. Arzt S, Baudin F, Barge A, et al. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology. 2001;279(2):439-446.
  37. Shtykova EV, Baratova LA, Fedorova NV, et al. Structural analysis of Influenza A virus matrix protein M1 and its self-assemblies at low pH. PLoS ONE. 2013;8(12):e82431.
  38. Shishkov A, Bogacheva E, Fedorova N, et al. Spatial structure peculiarities of influenza A virus matrix M1 protein in an acidic solution that simulates the internal lysosomal medium. The FEBS Journal. 2011;278(24):4905-4916.
  39. Zhang K, Wang Z, Liu X, et al. Dissection of influenza A virus M1 protein: pH-dependent oligomerization of N-terminal domain and dimerization of C-terminal domain. PLoS ONE. 2012;7(5):e37786.
  40. Zhang K, Wang Z, Fan G-Z, et al. Two polar residues within C-terminal domain of M1 are critical for the formation of influenza A virions. Cellular Microbiology. 2015;17(11):1583-1593.
  41. Yin C, Khan JA, Swapna GVT, et al. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. The Journal of Biological Chemistry. 2007;282(28):20584-20592.
  42. Wang W, Krug RM. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology. 1996;223(1):41-50.
  43. Guan R, Ma L-C, Leonard PG, et al. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(33):13468-13473.
  44. Ma L-C, Guan R, Hamilton K, et al. A second RNA-binding site in the NS1 protein of influenza B virus. Structure (London, England: 1993). 2016;24(9):1562-1572.
  45. Dauber B, Schneider J, Wolff T. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. Journal of Virology. 2006;80(23):11667-11677.
  46. Imai M, Watanabe S, Odagiri T. Influenza B virus NS2, a nuclear export protein, directly associates with the viral ribonucleoprotein complex. Archives of Virology. 2003;148(10):1873-1884.
  47. Paragas J, Talon J, O’Neill RE, et al. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. Journal of Virology. 2001;75(16):7375-7383.
  48. Cha T-A, Kao K, Zhao J, et al. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. Journal of Clinical Microbiology. 2000;38(2):839-845.
  49. Kiseleva IV, Klimov AI, Grigoryeva EP, et al. Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains. Vopr Virusol. 2005;50(2):14-18. (In Russ.)
  50. Buonagurio DA, Bechert TM, Yang C-F, et al. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process. Vaccine. 2006;24(12):2151-2160.
  51. Buonagurio DA, O’Neill RE, Shutyak L, et al. Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. Virology. 2006;347(2):296-306.
  52. Murphy BR, Park EJ, Gottlieb P, Subbarao K. An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters. Vaccine. 1997;15(12-13):1372-1378.
  53. Treanor JJ, Buja R, Murphy BR. Intragenic suppression of a deletion mutation of the nonstructural gene of an influenza A virus. Journal of Virology. 1991;65(8):4204-4210.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.